Compare Five Below Inc (FIVE) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five Below Inc vs Humana Inc — how do they compare? Five Below Inc trades at $201.19 (market cap $10.67B), while Humana Inc trades at $402.36 (market cap $48.96B). The key difference: Humana Inc is far larger — about 4.6× Five Below Inc's market cap, and Humana Inc pays a 0.87% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| FIVE | HUM | |
|---|---|---|
Market Cap | $10.67B | $48.96B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $409.42 |
52-Week Low | $131.94 | $163.67 |
Enterprise Value | $11.56B | $58.00B |
Dividend Yield | — | 0.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five Below (FIVE) trades at $193.11, up 0.82% with a bullish technical signal despite mixed moving averages. The company demonstrates strong growth with revenue reaching $3.88 billion in 2025 and consistent earnings beats, including Q1 2026 EPS of $2.22 beating expectations of $1.77. Valuation metrics show a P/E of 24.34 and P/S of 2.11, while profitability remains solid with 8.67% net margin and 21.13% ROE. Recent news highlights store expansion to 2,000 locations and strategic investments in digital marketing.
FIVE presents a compelling growth story with analyst consensus pointing to 33% upside potential to $252.09 target. The stock benefits from strong institutional support (60% buy ratings) and positive earnings momentum, though investors should monitor competitive pressures in value retail and the sustainability of expansion-driven cash flow patterns. Current technical levels show support at $191 with resistance at $194.
Humana (HUM) trades at $406.70, up 0.17% on the day, and is currently above its consensus price target. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company has beaten earnings expectations for three consecutive quarters and is executing a strategic shift from membership growth to profitability, targeting a 3% Medicare Advantage margin by 2028. Revenue has grown consistently from $92.9B in 2022 to $129.7B in 2025.
The outlook is mixed. The company's strategic pivot and recent contract wins like the Illinois Medicaid contract present growth opportunities. However, significant risks include multiple legal investigations into statements on healthcare costs, declining net profit margins (from 3.02% in 2022 to 0.91% in 2025), and a high P/E ratio of 43.52. Analyst sentiment is cautious, with a majority 'Hold' rating and a consensus price target 13% below the current price.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
